Successful weight loss treatment should be realistic, medically supervised, and personalized for each patient, Dr
Aetnas typical PA requirements for Wegovy and Zepbound include: Documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea) Evidence of participation in a structured weight management program (diet, exercise, behavioral counseling) for a minimum period often 3 to 6 months Documentation that other weight loss interventions have been attempted Prescriber must be a physician, NP, or PA with appropriate prescribing authority Prior authorization is not a denial it is a documentation requirement
Formulations: Immediate-release, SR (sustained release, twice daily), and XL (extended release, once daily) Typical doses: 150300 mg/day for depression
These choices help people get through the nausea phase that can happen when doses increase
Longitudinal studies have indicated that depressive symptoms correlate with elevated HbA1c levels in elderly patients either at risk for or currently experiencing depression [129]
It is outlined in Section 503A and Section 503B of the U.S
